Medical technology company, Admedus
(ASX:AHZ) has today announced an exclusive distribution agreement with Medical Instruments S.p.A to market and distribute its ADAPT technology in Italy.
Under the agreement, Medical Instruments will initially distribute the ADAPT treatment for congenital and structural heart defects and disease.
Admedus COO, David St Dennis says the company is delighted to partner with Medical Instruments to distribute the unique, world leading technology to the patients and surgeons of Italy.
The company says it anticipates solid growth and development in the key market.
Shares in Admedus
(ASX:AHZ) are trading 2.08 per cent higher to 24c.
